watch for drug interactions with the new antiarrhythmic, Tikosyn (dofetilide)
October 2000
Pharmacists are being warned to watch for drug interactions with the new antiarrhythmic, Tikosyn (dofetilide).
Tikosyn is used to control atrial fibrillation or flutter.
But it can cause serious ventricular arrhythmias...especially if patients have poor renal function or take it with certain drugs.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote